We detected a trend toward a higher baseline expression of 5-LO/ALOX5 mRNA and a significantly elevated baseline expression of LTC4S mRNA in monocytes from AD patients compared to HVs (Fig. 2C and D). This evidence concerns the gene LTC4S and Alzheimer disease.